These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 23495734)

  • 1. Studies on lactoferrin nanoparticles of gambogic acid for oral delivery.
    Zhang ZH; Wang XP; Ayman WY; Munyendo WL; Lv HX; Zhou JP
    Drug Deliv; 2013 Feb; 20(2):86-93. PubMed ID: 23495734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-octyl-N-arginine-chitosan (OACS) micelles for gambogic acid oral delivery: preparation, characterization and its study on in situ intestinal perfusion.
    Yu F; He C; Waddad AY; Munyendo WL; Lv H; Zhou J; Zhang Q
    Drug Dev Ind Pharm; 2014 Jun; 40(6):774-82. PubMed ID: 23679668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization, and in vitro/vivo studies of oleanolic acid-loaded lactoferrin nanoparticles.
    Xia X; Liu H; Lv H; Zhang J; Zhou J; Zhao Z
    Drug Des Devel Ther; 2017; 11():1417-1427. PubMed ID: 28533680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
    Pandey V; Gajbhiye KR; Soni V
    Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a More Efficient Albumin-Based Delivery System for Gambogic Acid with Low Toxicity for Lung Cancer Therapy.
    Zhang Y; Yang Z; Tan X; Tang X; Yang Z
    AAPS PharmSciTech; 2017 Aug; 18(6):1987-1997. PubMed ID: 27933587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment.
    Huang R; Li J; Kebebe D; Wu Y; Zhang B; Liu Z
    Drug Deliv; 2018 Nov; 25(1):757-765. PubMed ID: 29528244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery.
    Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y
    Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gambogic acid-loaded PEG-PCL nanoparticles act as an effective antitumor agent against gastric cancer.
    Zhang D; Zou Z; Ren W; Qian H; Cheng Q; Ji L; Liu B; Liu Q
    Pharm Dev Technol; 2018 Jan; 23(1):33-40. PubMed ID: 29069711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
    Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
    Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Chen YC
    Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of in vitro and in vivo antitumor effects of gambogic acid-loaded layer-by-layer self-assembled micelles.
    Ke Z; Yang L; Wu H; Li Z; Jia X; Zhang Z
    Int J Pharm; 2018 Jul; 545(1-2):306-317. PubMed ID: 29654896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-octyl-N-arginine-chitosan micelles for gambogic acid intravenous delivery: characterization, cell uptake, pharmacokinetics, and biodistribution.
    Yu F; Jiang F; Tang X; Wang B
    Drug Dev Ind Pharm; 2018 Apr; 44(4):615-623. PubMed ID: 29188736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
    Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
    J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical potential of tacrolimus-loaded albumin nanoparticles having targetability to rheumatoid arthritis tissues.
    Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi HG; Park ES; Youn YS
    Int J Pharm; 2016 Jan; 497(1-2):268-76. PubMed ID: 26657273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease.
    Hu K; Shi Y; Jiang W; Han J; Huang S; Jiang X
    Int J Pharm; 2011 Aug; 415(1-2):273-83. PubMed ID: 21651967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
    Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y
    Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment.
    Neupane YR; Srivastava M; Ahmad N; Kumar N; Bhatnagar A; Kohli K
    Int J Pharm; 2014 Dec; 477(1-2):601-12. PubMed ID: 25445972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboplatin- and Etoposide-Loaded Lactoferrin Protein Nanoparticles for Targeting Cancer Stem Cells in Retinoblastoma In Vitro.
    Narayana RVL; Jana P; Tomar N; Prabhu V; Nair RM; Manukonda R; Kaliki S; Coupland SE; Alexander J; Kalirai H; Kondapi AK; Vemuganti GK
    Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):13. PubMed ID: 34784412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.